NO158678C - Analogifremgangsmaate til fremstilling av terapeutisk aktive vicinale dihydroksyalkyl-xantiner. - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive vicinale dihydroksyalkyl-xantiner.

Info

Publication number
NO158678C
NO158678C NO823239A NO823239A NO158678C NO 158678 C NO158678 C NO 158678C NO 823239 A NO823239 A NO 823239A NO 823239 A NO823239 A NO 823239A NO 158678 C NO158678 C NO 158678C
Authority
NO
Norway
Prior art keywords
omega
atoms
xantines
dihydroxycyl
preparation
Prior art date
Application number
NO823239A
Other languages
English (en)
Norwegian (no)
Other versions
NO158678B (no
NO823239L (no
Inventor
Harald Furrer
Hiristo Anagnostopulos
Ulrich Gebert
Heinz-Joachim Hinze
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO823239L publication Critical patent/NO823239L/no
Publication of NO158678B publication Critical patent/NO158678B/no
Publication of NO158678C publication Critical patent/NO158678C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/09Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
    • C07C29/10Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/34Halogenated alcohols
    • C07C31/42Polyhydroxylic acyclic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/08Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20Free hydroxyl or mercaptan
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
NO823239A 1981-09-26 1982-09-24 Analogifremgangsmaate til fremstilling av terapeutisk aktive vicinale dihydroksyalkyl-xantiner. NO158678C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813138397 DE3138397A1 (de) 1981-09-26 1981-09-26 "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"

Publications (3)

Publication Number Publication Date
NO823239L NO823239L (no) 1983-03-28
NO158678B NO158678B (no) 1988-07-11
NO158678C true NO158678C (no) 1988-10-19

Family

ID=6142714

Family Applications (1)

Application Number Title Priority Date Filing Date
NO823239A NO158678C (no) 1981-09-26 1982-09-24 Analogifremgangsmaate til fremstilling av terapeutisk aktive vicinale dihydroksyalkyl-xantiner.

Country Status (18)

Country Link
US (2) US4616020A (xx)
EP (1) EP0075850B1 (xx)
JP (1) JP2550301B2 (xx)
KR (1) KR880002300B1 (xx)
AT (1) ATE17005T1 (xx)
AU (1) AU554227B2 (xx)
CA (1) CA1286292C (xx)
DE (2) DE3138397A1 (xx)
DK (1) DK148844C (xx)
ES (3) ES8606346A1 (xx)
FI (1) FI73681C (xx)
GR (1) GR76734B (xx)
HU (1) HU186125B (xx)
IE (1) IE53911B1 (xx)
IL (1) IL66864A0 (xx)
NO (1) NO158678C (xx)
PT (1) PT75604B (xx)
ZA (1) ZA827012B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
AU607709B2 (en) * 1986-08-07 1991-03-14 Medice Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg A micelle containing a hydrophobic pharmaceutically active substance
FR2611716A1 (fr) * 1987-03-06 1988-09-09 Uriach Cia Sa J Derives de diisobutylxanthine substituee en position 7 utiles comme bronchodilatateurs, procede pour leur preparation et composition pharmaceutique les contenant
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤
DE4109169A1 (de) * 1991-03-20 1992-09-24 Koehler Chemie Dr Franz Wasserloesliche nicht ionische roentgenkontrastmittel sowie mittel und verfahren zu ihrer herstellung
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US6469017B1 (en) * 1998-01-16 2002-10-22 Cell Therapeutics, Inc. Method of inhibiting interleukin-12 signaling
US5473070A (en) * 1992-11-16 1995-12-05 Cell Therapeutics, Inc. Substituted long chain alcohol xanthine compounds
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
EP0799040B1 (en) * 1994-12-13 2003-08-20 Euroceltique S.A. Trisubstituted thioxanthines
WO1996018399A1 (en) * 1994-12-13 1996-06-20 Euro-Celtique, S.A. Aryl thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists
ES2215146T3 (es) * 2000-09-08 2004-10-01 Cv Therapeutics, Inc. Utilizacion de ribosidos purina como antiarritmicos.
JP4483683B2 (ja) 2005-04-28 2010-06-16 日立工機株式会社 連ねじドライバ

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2575344A (en) * 1946-03-01 1951-11-20 State Of Iowa Dihydroxypropyl theophylline
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
DE2335170C2 (de) * 1973-07-11 1989-07-20 Hoechst Ag, 6230 Frankfurt 1,3-Dialkyl-7-(hydroxyalkyl)-xanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US4031218A (en) * 1976-04-28 1977-06-21 Mallinckrodt, Inc. 7-(2,3-Dihydroxypropyl-1,3-di-n-propylxanthine and a pharmaceutical composition containing same useful as a bronchial muscle relaxant
US4397779A (en) * 1978-08-09 1983-08-09 Baxter Travenol Laboratories, Inc. Preparation of xanthine tracers
IL59664A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
IT1195267B (it) * 1980-04-15 1988-10-12 Abc Ist Biolog Chem Spa Derivati teofillinmetildiossolanici,procedimento per la loro preparazione e relative composizioni farmaceutiche

Also Published As

Publication number Publication date
AU554227B2 (en) 1986-08-14
ES8406479A1 (es) 1984-08-01
IE53911B1 (en) 1989-04-12
FI73681C (fi) 1987-11-09
FI823274A0 (fi) 1982-09-23
EP0075850A3 (en) 1983-07-27
ZA827012B (en) 1983-07-27
DE3138397A1 (de) 1983-04-07
IL66864A0 (en) 1982-12-31
JP2550301B2 (ja) 1996-11-06
DE3268041D1 (en) 1986-01-30
EP0075850B1 (de) 1985-12-18
ES528122A0 (es) 1984-08-01
KR840001576A (ko) 1984-05-07
US4713455A (en) 1987-12-15
HU186125B (en) 1985-06-28
IE822322L (en) 1983-03-26
DK148844C (da) 1986-03-17
AU8866382A (en) 1983-04-14
CA1286292C (en) 1991-07-16
DK426982A (da) 1983-03-27
PT75604B (de) 1985-07-26
JPS5867687A (ja) 1983-04-22
KR880002300B1 (ko) 1988-10-22
ES528123A0 (es) 1984-08-16
ES515936A0 (es) 1986-04-01
ES8606346A1 (es) 1986-04-01
FI823274L (fi) 1983-03-27
NO158678B (no) 1988-07-11
GR76734B (xx) 1984-08-30
EP0075850A2 (de) 1983-04-06
NO823239L (no) 1983-03-28
FI73681B (fi) 1987-07-31
ES8407048A1 (es) 1984-08-16
ATE17005T1 (de) 1986-01-15
DK148844B (da) 1985-10-21
PT75604A (de) 1982-10-01
US4616020A (en) 1986-10-07

Similar Documents

Publication Publication Date Title
NO158678C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive vicinale dihydroksyalkyl-xantiner.
GB1500043A (en) Benzimidazole derivatives their preparation and their use in affecting gastric acid secretion
FI802173A (fi) Terapeutiskt aktiva substituerade piperidiner och pyrrolidiner
ATE2427T1 (de) (dl)-16-phenoxy- und 16-substituierte phenoxy-9- keto prostatriensaeuren und derivate, verfahren zu deren herstellung und ihre pharmazeutischen zusammensetzungen.
ES8303355A1 (es) Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles.
FR2445329A1 (fr) Derives du 11-bromo-14-oxo-15-hydroxy-imino-e-homo-eburnane, leur preparation et leur utilisation comme medicament
ES2028838T3 (es) Procedimiento para la obtencion de nuevos derivados de 4,5-hidro-oxazoles.
ES519532A0 (es) Procedimiento de preparacion de derivados de imidazolidina.
KR880007070A (ko) 백내장 치료용 약학 조성물
IT1159151B (it) Steroidi esterificati nella posizione 17 e tioesterificati nella posizione 21 loro procedimento di preparazione e loro uso medicinale
IT1131887B (it) Glicosidi antraciclinici
SE8204791L (sv) Sett att framstella alkoxivinkaminsyraestrar och alkoxiapovinkaminsyraestrar
FR2448544A1 (fr) Derives de thiazole et leur application en therapeutique
SE8005309L (sv) Nya 5alfa-pregnan-20-ol-derivat och salter derav med syror, sett for framstellning samt anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar
FR2434142A1 (fr) Procede de preparation d'amino-hydroxyanthraquinones
SE7806445L (sv) Alkanolaminderivat och sett for deras framstellning